Komori
StemCell Institute (7096) · InitiativeAdvanced

Shareholder Returns and Improved Capital Efficiency through Share Repurchases

First written in FY2025. 1 of 3 entries say "Achieved", first in FY2026-H1. Latest entry: FY2026.

3entries
2years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2025AchievedFY2026-H1 – FY20262025: 220252026: 12026
Same theme, other companies
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 197 companies compared. The sentences above are computed from all 197.Comparing 200 of the theme's 1155 threads.
Moved together

"Recruitment and Development of Specialist Talent and Digitalization of Operations" moved the same way as this thread, in the same document, in 2 of its 3 moves.

222222★123456
  1. ★This thread
  2. 1Recruitment and Development of Specialist Talent and Digitalization of Operations2×
  3. 2Business expansion into cells derived from umbilical cord and other perinatal tissues2×
  4. 3Launch of Umbilical Cord Tissue Storage Service2×
  5. 4Support for Clinical Research in Regenerative Medicine and Cell Therapy Using Umbilical Cord Blood2×
  6. 5Overseas business expansion focused on Asia2×
  7. 6Expansion of Cell Processing and Storage Capacity2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for StemCell Institute yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.